Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.5K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.6K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

325
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
325

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of dental disease in eared seals (family Otariidae): a Delphi approach.

Frontiers in veterinary science·2025
Same author

An Exploration of Culture in General Surgery Training Programs: A Scoping Review.

Annals of surgery·2025
Same author

Early Flap Reconstruction and Infection Rates in Open Lower Extremity Fractures: A Systematic Review and Meta-analysis.

Plastic and reconstructive surgery. Global open·2025
Same author

From printer to patient: A scoping review and new classification of ready-to-use three-dimensional printed constructs in autologous breast reconstruction.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2025
Same author

A Scoping Review of End-of-Life Discussions and Palliative Care: Implications for Neurological Intensive Care in Latin America and the Caribbean.

Journal of palliative medicine·2024
Same author

Association Between Environmental Air Pollution and Thyroid Cancer and Nodules: A Systematic Review.

Thyroid : official journal of the American Thyroid Association·2024
Same journal

"It's Not Just Based on Behavior": A Qualitative Study of Stakeholder Perspectives on Women's HIV Vulnerability in the United States.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same journal

Serious Games for HIV Prevention Among Adolescents in a Global Context: A Scoping Review.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same journal

Stigma, Mental Health, and HIV Adherence: A Cross-Sectional Structural Equation Modeling Study Exploring Direct and Indirect Effects Among School-Engaged Ugandan Adolescents Living With HIV.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same journal

Discrimination and the Mediating Role of Self-Esteem on Psychopathology and Retention in Care: A Cross-Sectional Study With People Living With HIV in Myanmar.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same journal

Equity in U.S. Solid Organ Transplantation for People Living With HIV: An Integrative Review of Barriers, Policies, and Interventions.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same journal

Biopsychosocial Determinants of Frailty in Older People Living With HIV in China: A Bayesian Network Analysis.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.5K

Implementing HIV Testing in Substance Use Treatment Programs: A Systematic Review.

Claire A Simeone, Stella M Seal, Christine Savage

    The Journal of the Association of Nurses in AIDS Care : JANAC
    |January 31, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Implementing rapid HIV testing in drug treatment programs is effective and feasible. Key challenges include securing organizational support and sustainable funding for widespread adoption.

    Keywords:
    HIVimplementationprogramrapid testingsubstance use

    More Related Videos

    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
    23:56

    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

    Published on: October 31, 2010

    17.4K
    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

    18.5K

    Related Experiment Videos

    Last Updated: Mar 26, 2026

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    19.5K
    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
    23:56

    Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

    Published on: October 31, 2010

    17.4K
    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
    05:46

    Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

    Published on: April 9, 2014

    18.5K

    Area of Science:

    • Public Health
    • Infectious Diseases
    • Substance Use Disorders

    Background:

    • Individuals with substance use disorders face elevated risks for HIV acquisition and poorer health outcomes.
    • Late HIV diagnosis in this population leads to increased morbidity, mortality, and healthcare expenses.

    Purpose of the Study:

    • To systematically review evidence on the effectiveness and feasibility of integrating HIV testing within US substance use treatment programs.
    • To identify strategies, barriers, and facilitators for implementing HIV testing in these settings.

    Main Methods:

    • A systematic literature search identified 535 articles, with 17 selected for full-text review.
    • Included studies comprised quantitative, qualitative, or mixed-method designs assessing testing rates, acceptance, and cost-effectiveness.
    • Eight organizational surveys detailed barriers and facilitators to testing implementation.

    Main Results:

    • Evidence supports the effectiveness and feasibility of rapid, routine, and streamlined HIV testing in substance use treatment programs.
    • High client and staff acceptance rates were observed in implemented testing strategies.
    • Primary challenges identified were the need for robust organizational support and sustainable funding.

    Conclusions:

    • HIV testing is an effective and feasible intervention within substance use treatment programs.
    • Addressing organizational support and funding are critical for successful and sustainable implementation of HIV testing services.